Developer docs
API playgroundTry for free, no card

Search company profiles

AppMed Inc.

Full company profile

uuid028obhc

Namestring
AppMed Inc.
Legal namestring
AppMed Inc.
Websiteurl
appmed.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

AppMed Inc. is a privately held Canadian healthcare technology company headquartered in Laval, Quebec, founded in 2017. The company operates the AppMed platform, a web-based Software as a Medical Device (SaMD) that has been approved by Health Canada as a Class II medical device. The platform is purpose-built for medications with narrow therapeutic windows and consolidates three integrated modules—Dosage Optimization using validated pharmacokinetic/pharmacodynamic models with Bayesian algorithms, Dosage Monitoring through remote therapeutic drug monitoring (RTDM) with patient-reported outcomes and microsampling biomarkers, and Dosage Adherence via connected medication dispensing system devices—into a single clinical environment. It is deployed across three therapeutic areas: Pain Management (including opioid tapering and deprescribing), Women's Health (menopause and individualized HRT monitoring), and Mental Health (ADHD treatment optimization, schizophrenia monitoring, and depression protocols), with validated psychiatric instruments including ADHD-RS, Conners, BRIEF, PANSS, BPRS, PHQ-9, and GAD-7.

The platform is hosted on AWS Montreal infrastructure, with security designed in alignment with SOC 1, SOC 2 Type II, ISO 27001, ISO 27018, Quebec Law 25, and PIPEDA, and is positioned as a 100% Canadian solution. Customers include healthcare professionals, hospitals, pain clinics, mental health programs, research institutions, and pharmaceutical companies, with named clinical partners including Université de Montréal, McGill University Health Centre (MUHC), Hôpital Maisonneuve-Rosemont, Centre de recherche du CHU Sainte-Justine, and Hormonova Clinique. Patients access the platform directly through app.appmed.ca for health tracking, care team connectivity, self-collected microsamples, and patient-reported outcome submission.

AppMed generates revenue primarily through SaaS subscriptions to its clinical platform, supplemented by hardware distribution of Neoteryx Mitra VAMS microsampling devices and Harpera Microbiopsy Punch products as the exclusive Canadian distributor of Trajan Scientific and Medical. The go-to-market combines enterprise field sales targeted at healthcare organizations, channel partnerships including the Trajan distribution agreement, and a direct-to-consumer patient portal. Pricing is not publicly disclosed; customers are directed to request clinical demonstrations or volume quotes for microsampling products. The company is founder-controlled, with a multidisciplinary leadership team spanning clinical research, regulatory affairs, software validation, pharmacology, and health economics, and no external institutional investors have been disclosed.

Short descriptiontext

AppMed Inc. is a Canadian Health Canada-approved SaMD Class II company offering a web-based clinical platform for precision dosing, remote therapeutic drug monitoring, and medication adherence, serving healthcare organizations, clinicians, and patients across pain management, women's health, and mental health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLaval, Canada
HQ citystring
Laval
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support software, software as a medical device, remote therapeutic drug monitoring, medication adherence tracking, precision dosing platform
Industry5 codes
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Clinical Decision Support Software (Software as a Medical Device)
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to the AppMed™ clinical platform for healthcare organizations, clinicians, and research institutions. Platform includes dosage optimization, remote monitoring, and adherence tracking capabilities. Pricing likely tiered by organization size or feature modules.

appmed.ai
2Microsampling Products Distribution
TypeHardware Sales
Description

Distribution of Neoteryx® Mitra® VAMS® microsampling devices and Harpera® skin biopsy products as exclusive Canadian distributor. Revenue from product sales to clinical sites, research institutions, and pharmaceutical companies.

appmed.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

AppMed Inc. develops and sells AppMed™, a Health Canada approved Software as a Medical Device (SaMD) Class II web-based clinical platform that integrates three modules — Dosage Optimization (model-informed precision dosing via validated PK/PD and Bayesian algorithms), Dosage Monitoring (remote therapeutic drug monitoring with patient-reported outcomes and microsampling biomarkers), and Dosage Adherence (connected medication dispensing system tracking) — deployed across Pain Management, Women's Health, and Mental Health programs. The company also distributes Neoteryx® Mitra® VAMS® microsampling devices and Harpera® Microbiopsy products as the exclusive Canadian distributor for Trajan.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 96% surge in opioid toxicity deaths during COVID-19 pandemic driven by disrupted monitoring and reduced access to care for chronic pain patients
+9 more records
Product overview1 text field

AppMed Inc. offers AppMed™ as a unified Health Canada approved SaaMD Class II clinical digital platform combining three integrated solution modules — Dosage Optimization (model-informed precision dosing), Dosage Monitoring (remote therapeutic drug monitoring with patient-reported outcomes and microsampling), and Dosage Adherence (connected medication dispensing system monitoring) — deployed across three therapeutic areas: Pain Management (including opioid tapering and post-surgical monitoring), Women's Health (menopause/HRT care), and Mental Health (ADHD, schizophrenia, depression). The platform also distributes microsampling products including Mitra® VAMS® devices (exclusive Canadian distributor of Neoteryx® by Trajan) and Harpera® Microbiopsy devices for dermatology research.

Product and service9 records
1AppMed™ Platform
CategoryClinical Decision Support Software (Software as a Medical Device)
Description

Health Canada approved SaaMD Class II clinical digital platform that consolidates real-time patient-recorded data into comprehensive clinical profiles for healthcare professionals, clinicians, researchers, institutions, and partners, combining dosage optimization, continuous monitoring, and treatment adherence in a single environment.

2Dosage Optimization Solution
CategoryClinical Decision Support Module
Description

Model-informed precision dosing module using validated pharmacokinetic and pharmacodynamic models with Bayesian PK/PD algorithms, enabling individualized and safer titration for medications with narrow therapeutic windows (including a Population PK/PD calculator for ADHD).

3Dosage Monitoring Solution
CategoryRemote Patient Monitoring Module
Description

Remote therapeutic drug monitoring and clinical assessment module that tracks treatment response continuously using patient-reported outcomes, therapeutic drug monitoring, microsampling biomarkers, and connected physiological devices.

4Dosage Adherence Solution
CategoryMedication Adherence Module
Description

Medication dispensing system monitoring module that tracks adherence via connected MDS devices, enables remote dose adjustments, and provides early intervention alerts before unplanned visits become necessary.

5Pain Management Program
CategoryTherapeutic Area Program (Pain Management)
Description

Therapeutic-area offering covering post-operative pain management, opioid tapering programs, deprescribing protocols, and chronic pain management with continuous pain assessments, adherence tracking, and MME-guided PRO surveillance for clinicians and healthcare organizations.

6Women's Health Program
CategoryTherapeutic Area Program (Women's Health)
Description

Therapeutic-area offering for menopause care and hormone replacement therapy management using continuous real-time symptoms and period tracking to guide individualized HRT treatment decisions and detect therapeutic drift.

7Mental Health Program
CategoryTherapeutic Area Program (Mental Health)
Description

Therapeutic-area offering for monitoring neurodivergent conditions including ADHD, schizophrenia, and depression using validated PRO tools (ADHD-RS, Conners, BRIEF, PANSS, BPRS, PHQ-9, GAD-7) and a population PK/PD calculator for real-time therapeutic decisions and antipsychotic TDM.

8Mitra® VAMS® Microsampling Devices
CategoryDistributed Diagnostic Hardware
Description

Volumetric Absorptive Microsampling devices (VAMS) for at-home blood sample collection enabling therapeutic drug monitoring without clinic visits; Health Canada registered Class 1 DIV device, 120µL max volume, 99% sample acceptance rate, Hematocrit bias elimination, room-temperature stability up to one month. Available formats include sample pouches, microsampling kits (with prepaid return envelopes), 96-Autorack™ for laboratory automation, and long-term storage solutions.

9Harpera® Microbiopsy Punch
CategoryDistributed Research Hardware
Description

Scarless skin biopsy device using laser-cut stainless steel technology for dermatology research and clinical applications, with ergonomic handle, safety cap, and controlled punch actuation for reliable and reproducible sample collection in longitudinal studies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research collaboration in clinical digital health and precision medicine. Logo displayed in partner ecosystem section indicating formal collaborative relationship in research and development of digital health solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare research collaboration with major pediatric teaching hospital in Montreal. Logo displayed in partner ecosystem section indicating clinical research partnership.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partnership with major McGill University-affiliated hospital network. Logo displayed in partner ecosystem section indicating collaborative healthcare research and implementation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration with affiliated teaching hospital. Logo displayed in partner ecosystem section indicating therapeutic monitoring program partnership.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Specialized women's health clinic partnership for hormone replacement therapy monitoring and menopause care programs. Logo displayed in partner ecosystem.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive Canadian distributor agreement for Neoteryx® microsampling products including Mitra® VAMS® devices, hemaPEN®, and related products. AppMed serves as the exclusive Canadian channel partner for Trajan's microsampling technology. Also distributes Harpera® Microbiopsy Punch products.

7Divoco
Strategic tierMinorTypeOthers
Description

Partner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

appmed.ai
8LOKQualiT
Strategic tierMinorTypeOthers
Description

Partner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

appmed.ai
Strategic tierMinorTypeOthers
Description

Partner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

Strategic tierMinorTypeOthers
Description

Partner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

11Cedar Strategies
Strategic tierMinorTypeOthers
Description

Partner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

appmed.ai
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Mahana Therapeutics develops FDA-authorized prescription digital therapeutics for chronic conditions including IBS and tinnitus. Comparable as a regulated digital therapeutics company pursuing therapeutic area specialization with clinical evidence requirements.

2Trajan Scientific and Medical
TypeOthers
Description

Trajan is the manufacturer of Neoteryx® Mitra® VAMS® microsampling technology and Harpera® Microbiopsy devices. AppMed is Trajan's exclusive Canadian distributor, making Trajan both a supplier and a strategic partner for the hardware component of AppMed's offering.

TypeEmerging player
Description

Medisafe is a digital medication adherence platform with connected pill bottles and patient engagement tools. Comparable to AppMed's adherence module but without PK/PD dosing optimization or SaMD regulatory classification.

TypeBroad incumbent
Description

Teva's Digihaler system combines connected inhalers with software for asthma/COPD adherence tracking. Comparable as a large pharmaceutical player integrating connected hardware and software for adherence and remote monitoring in chronic conditions.

TypeDirect peer
Description

InsightRX provides model-informed precision dosing software for clinicians, leveraging patient-specific factors and therapeutic drug monitoring to individualize medication dosing. Highly comparable to AppMed's platform for both dosing optimization and TDM workflows.

TypeDirect peer
Description

DoseMeRx is a model-informed precision dosing SaaS platform using Bayesian PK/PD algorithms to optimize dosing for antibiotics, anticoagulants, and other narrow therapeutic window drugs. Directly comparable to AppMed's dosage optimization module, though focused on hospital pharmacy workflows.

7Cedar Strategies
TypeOthers
Description

Listed as a partner/consulting collaborator in AppMed's ecosystem. Although direct comparability is limited, they are an ecosystem participant supporting the company.

TypeEmerging player
Description

Big Health provides digital therapeutics for insomnia (Sleepio) and anxiety (Daylight), with FDA clearance as digital therapeutics. Comparable as a digital therapeutic player in mental health, though focused on sleep/anxiety versus AppMed's ADHD/schizophrenia focus.

9Oracle Health (formerly Cerner)
TypeBroad incumbent
Description

Oracle Health provides enterprise EHR and population health platforms used by major health systems. Comparable as a broad incumbent in clinical decision support with potential to bundle precision dosing functionality that competes with AppMed's SaMD.

TypeBroad incumbent
Description

Epic's Beaker laboratory information system and broader EHR platform dominate hospital clinical workflows and decision support in North America. Represents both a potential integration partner and competitive threat as Epic adds precision medicine capabilities to its enterprise platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AppMed Inc.

Clinical Decision Support Software (Software as a Medical Device)appmed.ai

AppMed Inc. is a Canadian Health Canada-approved SaMD Class II company offering a web-based clinical platform for precision dosing, remote therapeutic drug monitoring, and medication adherence, serving healthcare organizations, clinicians, and patients across pain management, women's health, and mental health.

What AppMed Inc. does

AppMed Inc. is a privately held Canadian healthcare technology company headquartered in Laval, Quebec, founded in 2017. The company operates the AppMed platform, a web-based Software as a Medical Device (SaMD) that has been approved by Health Canada as a Class II medical device. The platform is purpose-built for medications with narrow therapeutic windows and consolidates three integrated modules—Dosage Optimization using validated pharmacokinetic/pharmacodynamic models with Bayesian algorithms, Dosage Monitoring through remote therapeutic drug monitoring (RTDM) with patient-reported outcomes and microsampling biomarkers, and Dosage Adherence via connected medication dispensing system devices—into a single clinical environment. It is deployed across three therapeutic areas: Pain Management (including opioid tapering and deprescribing), Women's Health (menopause and individualized HRT monitoring), and Mental Health (ADHD treatment optimization, schizophrenia monitoring, and depression protocols), with validated psychiatric instruments including ADHD-RS, Conners, BRIEF, PANSS, BPRS, PHQ-9, and GAD-7.

The platform is hosted on AWS Montreal infrastructure, with security designed in alignment with SOC 1, SOC 2 Type II, ISO 27001, ISO 27018, Quebec Law 25, and PIPEDA, and is positioned as a 100% Canadian solution. Customers include healthcare professionals, hospitals, pain clinics, mental health programs, research institutions, and pharmaceutical companies, with named clinical partners including Université de Montréal, McGill University Health Centre (MUHC), Hôpital Maisonneuve-Rosemont, Centre de recherche du CHU Sainte-Justine, and Hormonova Clinique. Patients access the platform directly through app.appmed.ca for health tracking, care team connectivity, self-collected microsamples, and patient-reported outcome submission.

AppMed generates revenue primarily through SaaS subscriptions to its clinical platform, supplemented by hardware distribution of Neoteryx Mitra VAMS microsampling devices and Harpera Microbiopsy Punch products as the exclusive Canadian distributor of Trajan Scientific and Medical. The go-to-market combines enterprise field sales targeted at healthcare organizations, channel partnerships including the Trajan distribution agreement, and a direct-to-consumer patient portal. Pricing is not publicly disclosed; customers are directed to request clinical demonstrations or volume quotes for microsampling products. The company is founder-controlled, with a multidisciplinary leadership team spanning clinical research, regulatory affairs, software validation, pharmacology, and health economics, and no external institutional investors have been disclosed.

AppMed Inc. firmographics

Firmographics
Name
AppMed Inc.
Legal name
AppMed Inc.
Website
https://appmed.ai
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
AppMed Inc. is a Canadian Health Canada-approved SaMD Class II company offering a web-based clinical platform for precision dosing, remote therapeutic drug monitoring, and medication adherence, serving healthcare organizations, clinicians, and patients across pain management, women's health, and mental health.
Ownership category
akta.pro rank

AppMed Inc. industry classification

Industry
Product category
Clinical Decision Support Software (Software as a Medical Device)
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Clinical decision support software
  • Software as a medical device
  • Remote therapeutic drug monitoring
  • Medication adherence tracking
  • Precision dosing platform

Where AppMed Inc. is headquartered

Location

Headquarters

HQ city
Laval
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

AppMed Inc. business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Subscription-based access to the AppMed™ clinical platform for healthcare organizations, clinicians, and research institutions. Platform includes dosage optimization, remote monitoring, and adherence tracking capabilities. Pricing likely tiered by organization size or feature modules.
  2. Microsampling Products Distribution: Distribution of Neoteryx® Mitra® VAMS® microsampling devices and Harpera® skin biopsy products as exclusive Canadian distributor. Revenue from product sales to clinical sites, research institutions, and pharmaceutical companies.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

AppMed Inc. product offering

Product offering

Core offering

AppMed Inc. develops and sells AppMed™, a Health Canada approved Software as a Medical Device (SaMD) Class II web-based clinical platform that integrates three modules — Dosage Optimization (model-informed precision dosing via validated PK/PD and Bayesian algorithms), Dosage Monitoring (remote therapeutic drug monitoring with patient-reported outcomes and microsampling biomarkers), and Dosage Adherence (connected medication dispensing system tracking) — deployed across Pain Management, Women's Health, and Mental Health programs. The company also distributes Neoteryx® Mitra® VAMS® microsampling devices and Harpera® Microbiopsy products as the exclusive Canadian distributor for Trajan.

Product overview

AppMed Inc. offers AppMed™ as a unified Health Canada approved SaaMD Class II clinical digital platform combining three integrated solution modules — Dosage Optimization (model-informed precision dosing), Dosage Monitoring (remote therapeutic drug monitoring with patient-reported outcomes and microsampling), and Dosage Adherence (connected medication dispensing system monitoring) — deployed across three therapeutic areas: Pain Management (including opioid tapering and post-surgical monitoring), Women's Health (menopause/HRT care), and Mental Health (ADHD, schizophrenia, depression). The platform also distributes microsampling products including Mitra® VAMS® devices (exclusive Canadian distributor of Neoteryx® by Trajan) and Harpera® Microbiopsy devices for dermatology research.

Differentiator

Problem solved

Functional benefit

Products and services

  • AppMed™ Platform Health Canada approved SaaMD Class II clinical digital platform that consolidates real-time patient-recorded data into comprehensive clinical profiles for healthcare professionals, clinicians, researchers, institutions, and partners, combining dosage optimization, continuous monitoring, and treatment adherence in a single environment.
  • Dosage Optimization Solution Model-informed precision dosing module using validated pharmacokinetic and pharmacodynamic models with Bayesian PK/PD algorithms, enabling individualized and safer titration for medications with narrow therapeutic windows (including a Population PK/PD calculator for ADHD).
  • Dosage Monitoring Solution Remote therapeutic drug monitoring and clinical assessment module that tracks treatment response continuously using patient-reported outcomes, therapeutic drug monitoring, microsampling biomarkers, and connected physiological devices.
  • Dosage Adherence Solution Medication dispensing system monitoring module that tracks adherence via connected MDS devices, enables remote dose adjustments, and provides early intervention alerts before unplanned visits become necessary.
  • Pain Management Program Therapeutic-area offering covering post-operative pain management, opioid tapering programs, deprescribing protocols, and chronic pain management with continuous pain assessments, adherence tracking, and MME-guided PRO surveillance for clinicians and healthcare organizations.
  • Women's Health Program Therapeutic-area offering for menopause care and hormone replacement therapy management using continuous real-time symptoms and period tracking to guide individualized HRT treatment decisions and detect therapeutic drift.
  • Mental Health Program Therapeutic-area offering for monitoring neurodivergent conditions including ADHD, schizophrenia, and depression using validated PRO tools (ADHD-RS, Conners, BRIEF, PANSS, BPRS, PHQ-9, GAD-7) and a population PK/PD calculator for real-time therapeutic decisions and antipsychotic TDM.
  • Mitra® VAMS® Microsampling Devices Volumetric Absorptive Microsampling devices (VAMS) for at-home blood sample collection enabling therapeutic drug monitoring without clinic visits; Health Canada registered Class 1 DIV device, 120µL max volume, 99% sample acceptance rate, Hematocrit bias elimination, room-temperature stability up to one month. Available formats include sample pouches, microsampling kits (with prepaid return envelopes), 96-Autorack™ for laboratory automation, and long-term storage solutions.
  • Harpera® Microbiopsy Punch Scarless skin biopsy device using laser-cut stainless steel technology for dermatology research and clinical applications, with ergonomic handle, safety cap, and controlled punch actuation for reliable and reproducible sample collection in longitudinal studies.

Quantifiable outcome

  • 96% surge in opioid toxicity deaths during COVID-19 pandemic driven by disrupted monitoring and reduced access to care for chronic pain patients
  • +9 more outcomes

Companies that use AppMed Inc.

Customer profile

Named customers3 records

Segments8 records

Ideal customer profiles3 records

AppMed Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

AppMed Inc. partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Université de MontréalcoreStrategic or Co-development PartnerAcademic research collaboration in clinical digital health and precision medicine. Logo displayed in partner ecosystem section indicating formal collaborative relationship in research and development of digital health solutions.
  • Centre de recherche du Centre hospitalier universitaire Sainte-Justine (CR-CHU Sainte-Justine)coreStrategic or Co-development PartnerHealthcare research collaboration with major pediatric teaching hospital in Montreal. Logo displayed in partner ecosystem section indicating clinical research partnership.
  • McGill University Health Centre (MUHC)coreStrategic or Co-development PartnerClinical partnership with major McGill University-affiliated hospital network. Logo displayed in partner ecosystem section indicating collaborative healthcare research and implementation.
  • Hôpital Maisonneuve-Rosemont (HMR)coreStrategic or Co-development PartnerClinical collaboration with affiliated teaching hospital. Logo displayed in partner ecosystem section indicating therapeutic monitoring program partnership.
  • Hormonova CliniquecoreStrategic or Co-development PartnerSpecialized women's health clinic partnership for hormone replacement therapy monitoring and menopause care programs. Logo displayed in partner ecosystem.
  • Neoteryx® by Trajan Scientific and MedicalcoreChannel Partner/ Reseller/ DistributorExclusive Canadian distributor agreement for Neoteryx® microsampling products including Mitra® VAMS® devices, hemaPEN®, and related products. AppMed serves as the exclusive Canadian channel partner for Trajan's microsampling technology. Also distributes Harpera® Microbiopsy Punch products.
  • DivocominorOthersPartner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.
  • LOKQualiTminorOthersPartner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.
  • C3i (Centre de consultation et d'investigation)minorOthersPartner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.
  • ThessminorOthersPartner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.
  • Cedar StrategiesminorOthersPartner logo displayed in partner ecosystem section. Nature of partnership not explicitly detailed in available source material.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

AppMed Inc. competitors and assessment

Company assessment

Emerging players

  • Mahana Therapeutics: Mahana Therapeutics develops FDA-authorized prescription digital therapeutics for chronic conditions including IBS and tinnitus. Comparable as a regulated digital therapeutics company pursuing therapeutic area specialization with clinical evidence requirements.
  • Medisafe: Medisafe is a digital medication adherence platform with connected pill bottles and patient engagement tools. Comparable to AppMed's adherence module but without PK/PD dosing optimization or SaMD regulatory classification.
  • Big Health: Big Health provides digital therapeutics for insomnia (Sleepio) and anxiety (Daylight), with FDA clearance as digital therapeutics. Comparable as a digital therapeutic player in mental health, though focused on sleep/anxiety versus AppMed's ADHD/schizophrenia focus.

Others

  • Trajan Scientific and Medical: Trajan is the manufacturer of Neoteryx® Mitra® VAMS® microsampling technology and Harpera® Microbiopsy devices. AppMed is Trajan's exclusive Canadian distributor, making Trajan both a supplier and a strategic partner for the hardware component of AppMed's offering.
  • Cedar Strategies: Listed as a partner/consulting collaborator in AppMed's ecosystem. Although direct comparability is limited, they are an ecosystem participant supporting the company.

Broad incumbents

  • Teva Pharmaceuticals (Digihaler System): Teva's Digihaler system combines connected inhalers with software for asthma/COPD adherence tracking. Comparable as a large pharmaceutical player integrating connected hardware and software for adherence and remote monitoring in chronic conditions.
  • Oracle Health (formerly Cerner): Oracle Health provides enterprise EHR and population health platforms used by major health systems. Comparable as a broad incumbent in clinical decision support with potential to bundle precision dosing functionality that competes with AppMed's SaMD.
  • Epic Systems (Beaker): Epic's Beaker laboratory information system and broader EHR platform dominate hospital clinical workflows and decision support in North America. Represents both a potential integration partner and competitive threat as Epic adds precision medicine capabilities to its enterprise platform.

Direct peers

  • InsightRX: InsightRX provides model-informed precision dosing software for clinicians, leveraging patient-specific factors and therapeutic drug monitoring to individualize medication dosing. Highly comparable to AppMed's platform for both dosing optimization and TDM workflows.
  • DoseMeRx: DoseMeRx is a model-informed precision dosing SaaS platform using Bayesian PK/PD algorithms to optimize dosing for antibiotics, anticoagulants, and other narrow therapeutic window drugs. Directly comparable to AppMed's dosage optimization module, though focused on hospital pharmacy workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

AppMed Inc. social profiles

Digital presence

AppMed Inc. compliance and trust

Trust signal

Compliance6 records

AppMed Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AppMed Inc. leadership team

Management profile

Number of profiles

Profiles7 records

AppMed Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AppMed Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AppMed Inc.

What does AppMed Inc. do?

AppMed Inc. develops and sells AppMed™, a Health Canada approved Software as a Medical Device (SaMD) Class II web-based clinical platform that integrates three modules — Dosage Optimization (model-informed precision dosing via validated PK/PD and Bayesian algorithms), Dosage Monitoring (remote therapeutic drug monitoring with patient-reported outcomes and microsampling biomarkers), and Dosage Adherence (connected medication dispensing system tracking) — deployed across Pain Management, Women's Health, and Mental Health programs. The company also distributes Neoteryx® Mitra® VAMS® microsampling devices and Harpera® Microbiopsy products as the exclusive Canadian distributor for Trajan.

Is AppMed Inc. a public or private company?

AppMed Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AppMed Inc. founded?

AppMed Inc. was founded in 2017. It employs 1 to 10 people.

Where is AppMed Inc. based?

AppMed Inc. is headquartered in Laval, Canada, in the North America region.

How does AppMed Inc. make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are microsampling Products Distribution.

Who are AppMed Inc.'s main competitors?

Emerging players on record are Mahana Therapeutics, Medisafe and Big Health. Others are Trajan Scientific and Medical and Cedar Strategies. Broad incumbents are Teva Pharmaceuticals (Digihaler System), Oracle Health (formerly Cerner) and Epic Systems (Beaker). Direct peers are InsightRX and DoseMeRx.

Does AppMed Inc. have an API?

No public API is recorded for AppMed Inc..

What industry is AppMed Inc. in?

AppMed Inc.'s product category is Clinical Decision Support Software (Software as a Medical Device). Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software. Its NAICS code is 62151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales